ABSTRACT

https://www.ncbi.nlm.nih.gov/pubmed/20136678

Background:
Tinea pedis is a common skin disease affecting most of the population during their lifetime. Topical and systemic treatments give only temporary relief.

Objective:
To evaluate the efficacy and safety of a new topical treatment for moderate-to-severe tinea pedis.

Methods:
Fifty patients suffering from tinea pedis were treated in two stages: the active stage–single use of the topical solution for 45 min and cream twice weekly for 4 weeks; the preventive stage–cream application once weekly for 10 months.

Results:
Forty-five patients completed the active stage and achieved 76% cure rate. The medication was well tolerated; one patient dropped from the study because of very mild irritation. No other topical or systemic side effects were noted. The total cure rate of all patients who began the trial, including the preventive stage was 70%. The actual cure rate for those who completed the study entirely was 85% when accounting for the fact that several patients dropped out during the preventive stage.

Conclusions:
This novel treatment was found to be effective, well tolerated and safe in the treatment of moderate and severe tinea pedis during the active and the preventive stages.

ATHLETE’S FOOT – MORE THAN JUST A CREAM, BUT A TREATMENT WITH A 70+% CURE RATE
Dr. Shemer has reviewed our initial formulation of our Kibosh! Foot Lotion and found a 70+% cure rate (85% for those who completed the study). He states: “This novel treatment was found to be effective, well tolerated and safe in the treatment of moderate and severe tinea pedis during the active and the preventive stages.”

We think so too. Our one-time application of Kibosh! Foot Lotion was derived from this study, and can help take care of an ongoing Athlete’s Foot issue.  To learn more about Kibosh! Foot Lotion, click here.

To see Dr. Shemer’s review, click here:
https://www.ncbi.nlm.nih.gov/pubmed/20136678

Tags :